We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

36 hedge funds and large institutions have $8.16M invested in Lunai Bioworks in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,500% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

283% more call options, than puts

Call options by funds: $111K | Put options by funds: $29K

71% more funds holding

Funds holding: 21 → 36 (+15)

23% more capital invested

Capital invested by funds: $6.65M → $8.16M (+$1.5M)

0.02% more ownership

Funds ownership: 0.03% → 0.05% (+0.02%)

Holders
36
Holders Change
+15
Holders Change %
+71.43%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
15
Reduced
3
Closed
1
Calls
$111K
Puts
$29K
Net Calls
+$82K
Net Calls Change
-$224K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$785K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$407K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$296K
4
6CM
683 Capital Management
New York
+$252K
5
LCM
Laurion Capital Management
New York
+$211K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$224K
2
CSS
Cubist Systematic Strategies
Connecticut
-$48.7K
3
William Blair & Company
William Blair & Company
Illinois
-$34K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$7.4K

LNAI Hedge Fund Activity: Q4 2023 in Review

36 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2023, worth a combined $8.16M — up 23% from $6.65M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LNAI positions and 1 closed out — a net gain of 15 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $785K. The largest seller was Millennium Management, cutting an estimated $224K.

  • 36 institutional investors held Lunai Bioworks (LNAI) as of Q4 2023, up from 21 in Q3 2023.
  • Funds reported $8.16M of Lunai Bioworks stock for Q4 2023, up 23% quarter-over-quarter.
  • 16 funds opened new Lunai Bioworks positions in Q4 2023 and 1 closed out, a net change of +15 holders.
  • The largest Lunai Bioworks buyer in Q4 2023 was Morgan Stanley, an estimated $785K added.
  • The largest Lunai Bioworks seller in Q4 2023 was Millennium Management, an estimated $224K sold.

Based on aggregated 13F filings for Q4 2023.